Home/Filings/4/0001209191-21-027419
4//SEC Filing

White David 4

Accession 0001209191-21-027419

CIK 0001175505other

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 7:49 PM ET

Size

10.5 KB

Accession

0001209191-21-027419

Insider Transaction Report

Form 4
Period: 2021-04-16
White David
See Remarks
Transactions
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2021-04-1630,0000 total
    Exercise: $11.58Common Stock (30,000 underlying)
  • Disposition to Issuer

    Common Stock

    2021-04-16$38.00/sh33,423$1,270,0740 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2021-04-1625,0000 total
    Exercise: $5.25Common Stock (25,000 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the "Merger Agreement"), by and among the Five Prime Therapeutics, Inc. (the "Company"), Amgen Inc. ("Parent") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent ("Purchaser"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the "Merger"), effective as of April 16, 2021. Pursuant to the Merger Agreement, each issued and outstanding share of common stock of the Company, par value $0.001 per share ("Common Stock"), was converted into the right to receive $38.00 per share (the "Offer Price") in cash, without interest, minus any applicable withholding taxes.
  • [F2]Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option.
  • [F3]Not applicable.

Issuer

FIVE PRIME THERAPEUTICS, INC.

CIK 0001175505

Entity typeother

Related Parties

1
  • filerCIK 0001329049

Filing Metadata

Form type
4
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 7:49 PM ET
Size
10.5 KB